Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement.
Pediatr Allergy Immunol
; 23(4): 300-6, 2012 Jun.
Article
en En
| MEDLINE
| ID: mdl-22594930
This article is the result of consensus reached by a working group of clinical experts in paediatric allergology as well as representatives from an ethical committee and the European Medicine Agency (EMA). The manuscript covers clinical, scientific, regulatory and ethical perspectives on allergen-specific immunotherapy in childhood. Unmet needs are identified. To fill the gaps and to bridge the different points of view, recommendations are made to researchers, to scientific and patient organizations and to regulators and ethical committees. Working together for the benefit of the community is essential. The European Academy of Allergy and Clinical Immunology (EAACI) serves as the platform of such cooperation.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Desensibilización Inmunológica
Tipo de estudio:
Guideline
/
Prognostic_studies
Aspecto:
Ethics
Límite:
Child
/
Humans
Idioma:
En
Revista:
Pediatr Allergy Immunol
Asunto de la revista:
ALERGIA E IMUNOLOGIA
/
PEDIATRIA
Año:
2012
Tipo del documento:
Article
Pais de publicación:
Reino Unido